ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 500 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 250 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

megapharm ltd - carbamazepine - טבליות בשחרור ממושך - carbamazepine 600 mg - carboxamide derivatives - treatment of epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic depressive illness .

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine - אבקה להכנת תמיסה לזריקה - olanzapine 10 mg / 2 ml - diazepines, oxazepines, thiazepines and oxepines - treatment of agitation associated with schizophrenia and bipolar mania.

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

שמעון שסטוביץ בעמ - לחות ובישום הפנים לאחר גילוח

ישראל - עברית - Ministry of Health

שמעון שסטוביץ בעמ - רחצת הגוף

ישראל - עברית - Ministry of Health

שמעון שסטוביץ בעמ - בישום הפנים לאחר גילוח

ישראל - עברית - Ministry of Health

אן.אס.פי. בעמ - שמפו נגד קשקים

ישראל - עברית - Ministry of Health

בירנפלד יפה - שיפור מראה העור